EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

INTRAVENOUS KETOROLAC COMPARED WITH TRAMADOL FOR PAIN IN MILD-TO-MODERATE ACUTE PANCREATITIS: A SINGLE-BLIND RANDOMISED TRIAL

Asif Khan, Musarrat Hussain, Rafi Ullah, Muhammad Jawad Zahid, Muhammad Haider Ali, Imran Ullah, Laiba Ali, Unsia Fatima, Suleman Khan, Seemab Waheed, Aiman Ali, Sana Hamayun und 4 weitere

Khyber Journal of Medical Sciences · 30.06.2026 · 19 (2)

DOI: 10.70520/kjms.v19i2.804 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Khyber Journal of Medical Sciences, online erschienen am 30.06.2026. Verfasst von Asif Khan und 15 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the early analgesic effect and short-term tolerability of intravenous ketorolac and tramadol for adults with mild-to-moderate AP.

Methods

Single centre, parallel group, single blind trial was conducted in Hayatabad Medical Complex Peshawar from January to August 2024. In the group of adults with a numeric rating scale (NRS) pain score ?4 and who did not require intensive care, patients were randomly allocated in a 1:1 ratio to either ketorolac 30 mg intravenously three times daily or tramadol 25-50 mg intravenously three times daily. Change in NRS score at 2 hours after the first dose of the study drug was prespecified as the primary endpoint. In all, all randomised participants were analysed.

Results

60 participants were recruited, 30 in each arm. The baseline NRS score for the ketorolac arm was 8.13 (SD 1.25) and 7.97 (SD 1.13) in the tramadol arm. Mean 2-hour changes were -2.56 (SD 1.17) and -2.74 (SD 0.93), respectively. The reported between-group difference was 0.18 points (95% CI, -0.70 to 1.03; p = 0.70). No statistical differences were found between the pain scores at later assessments, satisfaction and hospital stay. Sedation occurred in 11/30 and 19/30 patients respectively (reported p = 0.03) and epigastric pain in 3/30 and 9/30 patients respectively (reported p = 0.04).

Conclusion

There was no difference identified in the early reduction of pain between ketorolac and tramadol. There were fewer episodes of sedation and epigastric pain noted with ketorolac but due to the small sample size, conclusions about safety are limited. Ketorolac may be used in place of opioids as an opioid-sparing agent if there is no contraindication for using an NSAID.

Zitieren

APA

Khan, A., Hussain, M., Ullah, R., Zahid, M. J., Ali, M. H., Ullah, I., Ali, L., Fatima, U., Khan, S., Waheed, S., Ali, A., Hamayun, S., Iltaf, M., Abuzar, S. M., Rehman, S., & Ahmad, W. (2026). INTRAVENOUS KETOROLAC COMPARED WITH TRAMADOL FOR PAIN IN MILD-TO-MODERATE ACUTE PANCREATITIS: A SINGLE-BLIND RANDOMISED TRIAL. Khyber Journal of Medical Sciences, 19(2). https://doi.org/10.70520/kjms.v19i2.804

Vancouver

Khan A, Hussain M, Ullah R, Zahid MJ, Ali MH, Ullah I, et al. INTRAVENOUS KETOROLAC COMPARED WITH TRAMADOL FOR PAIN IN MILD-TO-MODERATE ACUTE PANCREATITIS: A SINGLE-BLIND RANDOMISED TRIAL. Khyber Journal of Medical Sciences. 2026;19(2). doi:10.70520/kjms.v19i2.804

BibTeX
@article{Khan2026,
  author = {Khan, Asif and Hussain, Musarrat and Ullah, Rafi and Zahid, Muhammad Jawad and Ali, Muhammad Haider and Ullah, Imran and Ali, Laiba and Fatima, Unsia and Khan, Suleman and Waheed, Seemab and Ali, Aiman and Hamayun, Sana and Iltaf, Muhammad and Abuzar, Syed Muhammad and Rehman, Sher and Ahmad, Wiqas},
  title = {INTRAVENOUS KETOROLAC COMPARED WITH TRAMADOL FOR PAIN IN MILD-TO-MODERATE ACUTE PANCREATITIS: A SINGLE-BLIND RANDOMISED TRIAL},
  journal = {Khyber Journal of Medical Sciences},
  year = {2026},
  volume = {19},
  number = {2},
  doi = {10.70520/kjms.v19i2.804}
}
Kostenlos starten →